Brand Name | Status | Last Update |
---|---|---|
lbel effet parfait signs of age appearance minimizer foundation spf 20 fm | OTC monograph final | 2019-12-03 |
lbel effet parfait signs of age appearance minimizer foundation spf 20 fm claire 2 lbel effet parfait signs of age appearance minimizer foundation ... | OTC monograph final | 2021-07-28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | 1 | — | 1 | — | — | 2 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | 1 | — | — | 1 |
Communicable diseases | D003141 | — | — | — | — | 1 | — | — | 1 |
Pyelonephritis | D011704 | EFO_1001141 | N10-N16 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | — | 1 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | — | — | — | 1 |
Drug common name | Triapine |
INN | — |
Description | 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, also called Triapine) is substance of interest for the treatment of cancer. It is a thiosemicarbazone derivative of 3-aminopyridine-2-carboxaldehyde. It presents an N-N-S array of donor sites that strongly bind iron, robbing iron-containing enzymes of their prosthetic group.
|
Classification | Small molecule |
Drug class | tricyclic compounds |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NC(=S)N/N=C/c1ncccc1N |
PDB | — |
CAS-ID | 143621-35-6 |
RxCUI | — |
ChEMBL ID | CHEMBL231616 |
ChEBI ID | — |
PubChem CID | 9571836 |
DrugBank | — |
UNII ID | — |